Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
McGill University
$27,000.00
From Gene Variant to Ciliary Defect: An Integrated Zebrafish and CryoET Pipeline for PCD Diagnostics
FY 2025-26
Summary
Primary ciliary dyskinesia (PCD) is a rare genetic disorder in which tiny, moving structures called cilia do not work properly. Healthy cilia help clear mucus from the lungs and guide organs to the correct position during early development. When cilia fail, children often experience chronic cough, repeated infections, and, in some cases, heart or organ laterality defects. Although many genes are known to cause PCD, up to one third of patients still receive uncertain results from genetic testing. These unclear findings make diagnosis difficult and limit the use of new therapies that are tailored to a patient’s specific gene variant. Our project aims to solve this problem by using zebrafish as a rapid and reliable way to test whether specific genetic changes truly cause PCD. Zebrafish share key cilia structures with humans, and when their cilia malfunction, they show visible and measurable signs such as body curvature or fluid-filled cysts. By turning off a PCD-related gene in zebrafish and then adding back either a healthy or patient-specific version of the human gene, we can determine if the patient’s variant disrupts cilia function. We combine this approach with cutting-edge imaging called cryo-electron tomography, which allows us to see the internal architecture of cilia in remarkable detail. This technology lets us identify structural defects linked to harmful variants, giving a direct view of how a genetic change affects cilia at the molecular level. Together, these methods create a powerful platform for clarifying uncertain genetic results, improving diagnosis, and supporting the development of personalized treatments for children living with PCD.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
573255
Name
Shi Jessica
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
From Gene Variant to Ciliary Defect: An Integrated Zebrafish and CryoET Pipeline for PCD Diagnostics
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Ai-Assisted Protein Modeling; Cilia Structure; Ciliary Defects; Cryo-Electron Tomography; Gene Variants; Pcd Diagnosis; Personalized Diagnostics; Primary Ciliary Dyskinesia (Pcd); Zebrafish Model
Abstract
Primary ciliary dyskinesia (PCD) is a rare genetic disorder in which tiny, moving structures called cilia do not work properly. Healthy cilia help clear mucus from the lungs and guide organs to the correct position during early development. When cilia fail, children often experience chronic cough, repeated infections, and, in some cases, heart or organ laterality defects. Although many genes are known to cause PCD, up to one third of patients still receive uncertain results from genetic testing. These unclear findings make diagnosis difficult and limit the use of new therapies that are tailored to a patient’s specific gene variant. Our project aims to solve this problem by using zebrafish as a rapid and reliable way to test whether specific genetic changes truly cause PCD. Zebrafish share key cilia structures with humans, and when their cilia malfunction, they show visible and measurable signs such as body curvature or fluid-filled cysts. By turning off a PCD-related gene in zebrafish and then adding back either a healthy or patient-specific version of the human gene, we can determine if the patient’s variant disrupts cilia function. We combine this approach with cutting-edge imaging called cryo-electron tomography, which allows us to see the internal architecture of cilia in remarkable detail. This technology lets us identify structural defects linked to harmful variants, giving a direct view of how a genetic change affects cilia at the molecular level. Together, these methods create a powerful platform for clarifying uncertain genetic results, improving diagnosis, and supporting the development of personalized treatments for children living with PCD.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Shi, Jessica
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~